SEC Form 4/A · accession 0000899243-16-015921
Global Blood Therapeutics, Inc. · GBT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Jung Choi
Officer — See Remarks
Period of report
Feb 1, 2016
Accepted (ET)
Mar 14, 2016 · 6:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001629137
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 1, 2016 | A | 749 | $16.09 | A | 143,606 | D | |
| Common StockF2 | holding | — | — | — | 25,000 | I | By Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan.
- F2These shares were erroneously reported as being directly owned in the reporting person's original Form 4. These shares are held by The 2005 William Park and Jung Choi Family Trust and are held in trust for the benefit of the reporting person's children. The reporting person and her spouse are co-trustees of the trust.
Remarks
Chief Business and Strategy Officer